Stocks / NASDAQ / Oasmia Pharmaceutical AB

Oasmia Pharmaceutical AB

Our Opinion

Oasmia Pharmaceutical is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in developing and commercializing of some of their pharmaceutical products.

Supporting Evidence:

The company stated in the following press release that they conduct pre-clinical trials of their drugs on animals.

“Animal data indicate that a dose eight times the expected dose used in formulation in clinical trials is non-toxic.” Read the following article

Company Description

Oasmia Pharmaceutical AB is engaged in reaserch and development of drugs. It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. Its portfolio includes Paclical, Doxophos, Docecal, and OAS-19 for human health; and Paccal Vet and Doxophos Vet for animal health. [Source: MarketWatch]

Company Website: